# Yaodouwang.com

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yaodouwang-com

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.yaodouwang.com
- Latest round: Series C (Apr 14, 2021)
- Investors on record: 2

## About

Yaodouwang.com, based in China, operates as a specialized e-commerce platform serving the pharmaceutical and healthcare sectors, providing a range of products and services to both consumers and businesses.Founded in 2014 and headquartered in Beijing, China, Yaodouwang.com operates as a digital marketplace focused on pharmaceuticals and medical products. The company has completed 4 deals, with its most recent transaction occurring on April 14, 2021. Zhongxun Qiu serves as both the CEO and founder of the company.Yaodouwang, under Zhejiang Yilingshu Pharmaceutical Co., Ltd., provides a comprehensive range of products in the pharmaceutical and healthcare fields. Their e-commerce platform facilitates the online sale of pharmaceuticals, medical devices, health foods, and cosmetics, allowing individual consumers and businesses to purchase medical products efficiently while ensuring compliance with regulations. The Yaodouwang app supports B2C transactions and engages in B2B partnerships, catering to pharmacies and healthcare providers by enabling direct procurement of necessary products. Technical support for transaction processing and customer service further enhances their offerings, effectively addressing market demands in China.Yaodouwang generates revenue primarily through transaction fees from sales conducted on its platform. The business model includes direct sales to consumers as well as wholesale transactions to pharmacies and healthcare institutions, creating diverse revenue streams. Payments are processed through the app upon order completion, ensuring a seamless transaction experience. While specific pricing details are not disclosed, the revenue structure reflects various pricing tiers for individual consumers and institutional clients, addressing different needs associated with each customer segment. In January 2026, Yaodouwang.com raised CNY 141.4 million in venture debt funding from investor Asian Development Bank. The company plans to utilize this funding to expand distribution to pharmacies and community health centres and improve access to essential medicines outside hospitals.

## Funding rounds

- Series C, Apr 14, 2021 — Morgan Stanley Investment Management, Nanxi Investment

## Investors

- Morgan Stanley Investment Management — Series C
- Nanxi Investment — Series C